Business Wire

NTT-DOCOMO

Share
DOCOMO Cooperating on Open RAN Initiatives with 5 Global Operators

NTT DOCOMO, INC., a longtime promoter of the Open Radio Access Network (Open RAN) concept, announced today that the company is now cooperating with five global telecom operators: KT Corporation (KT) in South Korea, Vodafone Group Plc (Vodafone) in Europe, Smart Communications Inc. (Smart) in the Philippines, DISH Wireless (DISH) in the United States and Singtel in Singapore on Open RAN initiatives.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230226005031/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

OREX (Open RAN Ecosystem Experience) (Graphic: Business Wire)

KT and DOCOMO signed a memorandum of understanding in January 20221 to support Open RAN and are now verifying an Open RAN system. Smart successfully demonstrated Open RAN, a first in the Philippines. In addition, Vodafone and DOCOMO agreed in October 20222 to collaborate towards harmonizing mobile operator system integration and test processes. On February 3, the two firms published a white paper with a defined common test script.

Also, DISH plans to evaluate the product performance and stability of Open RAN at the Shared Open Lab, DOCOMO's Open RAN verification environment in Japan. Singtel and DOCOMO agreed to evaluate Open RAN technologies and explore an Open RAN introduction.

DOCOMO has also announced today that it has adopted the "OREXTM" (Open RAN Ecosystem Experience) brand to strengthen the support scheme for international telecom operators in delivering the Open RAN system. DOCOMO has been working with global vendors since 2021 to conduct technological collaboration.

Global interest continues to grow regarding Open RAN, which uses open and standardized wireless base-station specifications to enable the devices and systems of multiple telecom vendors to be interconnected in mobile networks. Operators that so far have been constructing networks incorporating devices from just a single vendor are now facing technical and verification challenges in their efforts to implement Open RAN. DOCOMO, as the world's only company to have constructed networks implemented with multiple vendors since the 4G era, is leveraging its expertise to support the Open RAN efforts of operators worldwide.

Vodafone, DISH, Singtel and DOCOMO will give a panel discussion entitled "On the Forefront of Open RAN Implementation" at MWC Barcelona 2023, the world’s largest mobile-related exhibition being held in Barcelona, Spain from February 27 to March 2.

Going forward, DOCOMO will continue to strengthen its cooperation with global partners under the OREX brand to make Open RAN a reality.

1 KT Corporation, NTT DOCOMO and Fujitsu Cooperate towards Test Facility Construction and Successful Interoperability Testing for Open RAN in Korea
https://www.docomo.ne.jp/english/info/media_center/pr/2022/0106_00.html
2 Vodafone and NTT DOCOMO sign MoU to cooperate to drive greater system integration and service efficiency in Open RAN
https://www.docomo.ne.jp/english/info/media_center/pr/2022/1025_00.html

OREX is a trademark of NTT DOCOMO, INC.

About NTT DOCOMO

NTT DOCOMO, Japan's leading mobile operator with over 86 million subscriptions, is one of the world's foremost contributors to 3G, 4G and 5G mobile network technologies. Beyond core communications services, DOCOMO is challenging new frontiers in collaboration with a growing number of entities ("+d" partners), creating exciting and convenient value-added services that change the way people live and work. Under a medium-term plan toward 2020 and beyond, DOCOMO is pioneering a leading-edge 5G network to facilitate innovative services that will amaze and inspire customers beyond their expectations.
https://www.docomo.ne.jp/english/

Appendix 1

Overview of OREX

Name

OREX (Open RAN Ecosystem Experience)

OREX Partners

1

AMD

2

Dell Technologies Japan Inc.

3

Fujitsu Limited

4

Hewlett Packard Japan, G.K.

5

Intel K.K.

6

Mavenir

7

NEC Corporation

8

NTT DATA Corporation

9

NVIDIA

10

Qualcomm Technologies

11

Red Hat

12

VMware K.K.

13

Wind River

Concept

NTT DOCOMO and OREX partners are now building an Open RAN ecosystem around the world to supply new wireless communications with multi-vendor interconnectivity experiences.

Appendix 2

Panel discussion at MWC Barcelona 2023

Title

On the Forefront of Open RAN Implementation

Date

Monday, February 27, 2023 from 15:45 to 16:15 (local time)

Venue

Broadcast Studio, Hall 4, MWC Barcelona 2023

Speakers

Mr. Sadayuki Abeta, OREX evangelist, NTT DOCOMO, INC.
Mr. Francisco Martin, Head of Open RAN, Vodafone Group Plc
Mr. Sidd Chenumolu, Vice President of Technology Development, DISH Wireless
Mr. Cheng Choon Si, VP of Technology, Strategy & Transformation, Singtel

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230226005031/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Daiichi Sankyo Announces the Initiation of the Development of Oral Triple Combination Lipid-Lowering Tablets to Support the Management of LDL-C30.8.2025 18:00:00 CEST | Press release

Initiation of the development of new oral triple combination tablets, aimed at improving adherence and outcomes in low-density lipoprotein cholesterol (LDL-C) management. Recent findings from MILOS and SANTORINI registries presented at ESC Congress 2025, highlight ongoing challenges in accurately assessing cardiovascular (CV) risk and helping patients reach LDL-C targets.1-5 Furthermore, data from a four-country cohort of the MILOS study support the real-world effectiveness and safety of bempedoic acid in both sexes.6 Simulation using SANTORINI data reveals the potential of improved LDL-C goal attainment with tailored oral combination therapy of statins, ezetimibe and bempedoic acid, in line with the latest 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias.7,8 Daiichi Sankyo has a long-standing commitment to easing treatment of cardiovascular disease (CVD) and exploring new treatment options that improve CVD outcomes and treatment adherence. Daiich

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial30.8.2025 16:30:00 CEST | Press release

- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society of Cardiology Congress 2025 -- Zilebesiran Demonstrated Clinically Meaningful Reductions in Office Systolic Blood Pressure in Patients with Uncontrolled Hypertension and High Cardiovascular Risk at Month 3 Primary Endpoint, with Continuous Control Through Month 6 -- Zilebesiran Displayed Encouraging Safety When Combined with Two or More Antihypertensives -- Results Support Biannual Dosing Regimen and Inform Phase 3 Trial Design: Trial Expected to Initiate by Year-End 2025 -- Alnylam to Host Webcast Investor Event on August 30, 2025, at 1:00 pm ET (7:00 pm CEST) - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced plans to initiate a Phase 3 cardiovascular outcomes trial (CVOT) to evaluate the potential of zilebesiran to reduce the risk of major adverse cardiovascular events. This decision is informed by results from t

Andersen Consulting styrker sine kompetencer inden for virksomhedstransformation med Fabric29.8.2025 17:01:00 CEST | Pressemeddelelse

Andersen Consulting udvider sin platform gennem en samarbejdsaftale med Fabric, der er et strategisk designfirma, der arbejder med organisationer for at integrere bæredygtighed, forsyningskæder og menneske-centreret innovation på tværs af kultur og drift. Fabric blev grundlagt i Japan i 2021 og arbejder sammen med virksomheder og globale brands om at skabe regenerative forretningsmodeller sammen samt bæredygtige brandstrategier og fremtidssikrede produkter. Ved hjælp af strategiske designmetoder og designfilosofi skaber virksomheden indsigtsbaseret transformation på tværs af forsyningskæder, brand og HR. Fabric er kendt for sin systemtænkning og sit engagement i social og miljømæssig bæredygtighed og fremmer desuden digitale transformationsinitiativer, der integrerer bæredygtighed, humankapital og AI. "Fabric er skabt for at hjælpe virksomheder med at blomstre gennem regenerative relationer til mennesker, samfund og forbundne, levende systemer," sagde James Hollow, der er grundlægger a

Andersen Consulting tilføjer samarbejdsfirmaet Skribble29.8.2025 16:28:00 CEST | Pressemeddelelse

Andersen Consulting udvider sine kompetencer inden for strategi og virksomhedstransformation gennem en samarbejdsaftale med Skribble, der er et rådgivningsfirma inden for digital teknologi og branding, der hjælper virksomheder i Sydøstasien med innovation og driftsmæssig transformation. Skribble, der blev etableret i 2020, tilbyder en bred vifte af services, herunder brand- og kommunikationsstrategi, digital markedsføring, specialudvikling af teknologi, forandringsledelse og platformsløsninger. Virksomheden hjælper organisationer inden for ejendomme, forbrugsvarer, bankverdenen og den offentlige sektor ved at sikre, at strategi og eksekvering er tæt forbundet – med henblik på at levere integrerede løsninger inden for brand, performance og teknologi. Skribbe fokuserer på procesoptimering har kreative og tekniske kompetencer, der hjælper kunderne med at skabe forandringer og vækst. "Hos Skribble arbejder vi på at omsætte kreativ energi til strategiske resultater," sagde Chan Leong, CEO f

BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)29.8.2025 12:00:00 CEST | Press release

Study met its primary endpoint of overall response rate (ORR), demonstrating clinically meaningful responses in rare B-cell lymphoma with high unmet needBeOne to submit data to global regulatory authorities for their review and potential approval BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from a Phase 1/2 study (BGB-11417-201) of sonrotoclax, a next-generation and potentially best-in-class investigational BCL2 inhibitor, in adult patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL), following treatment with a Bruton’s tyrosine kinase inhibitor (BTKi) and anti-CD20 therapy. BeOne plans to present the full data at an upcoming medical meeting. “For people with relapsed or refractory mantle cell lymphoma, the disease is aggressive, the treatment landscape fragmented, and the outcomes unacceptably poor. These topline results for sonrotoclax underscore its potential to deliver meaningful and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye